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Aim: To investigate clinical, laboratory and imaging features of COVID-19 patients in Bushehr, a southern
province of Iran. Materials & methods: A total of 148 COVID-19 patients were enrolled. The patients were
categorized into four groups including inpatients, outpatients, elderly and nonelderly. Clinical, laboratory
and computed tomography characteristics were analyzed and compared. Results: Levels of erythrocyte
sedimentation rate, CRP, lactate dehydrogenase and aspartate aminotransferas among inpatients were
higher than outpatients. There were significant differences in the levels of creatinine and blood urine ni-
trogen between elderly and nonelderly patients. The incidence of ground-glass opacities in inpatients was
significantly higher than in outpatients. Conclusion: COVID-19 is associated with more severe renal failure
in elderly patients. Elderly patients with underlying conditions are at increased risk of severe progression
of COVID-19.
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In December 2019, a series of fatal pneumonia cases of unknown etiology was identified in Wuhan City, Hubei
Province of China. In January 2020, the Chinese authorities reported that the causative agent was a previously
unknown coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In February 2020, the
WHO officially named the disease caused by the SARS-CoV-2 as coronavirus disease-2019 (COVID-19) [1,2]. Up
to 11 October 2020, COVID-19 had been recognized in 216 countries and territories, with a total number of
reported laboratory-confirmed cases being nearly 37 million and deaths being more than one million [3]. Iran is the
most affected country by COVID-19 in the Eastern Mediterranean region and the first cases of the disease were
reported on 20 February 2020. According to the last report of the WHO, published on 12 October 2020, there
were 496,253 laboratory-confirmed cases of the SARS-CoV-2 and 28,293 deaths due to the COVID-19 infection
in Iran [3].
Based on the genome sequence data, it has been revealed that SARS-CoV-2 is a member of the genus Betacoron-
avirus within the family Coronaviridae [4,5]. It is an enveloped virus with a single strand, positive-sense RNA genome.
Following transmission by inhalation of respiratory droplets, contact with contaminated surfaces or fecal-oral route,
and other means, viral replication takes place in cells of the respiratory and GI tracts [5]. The average incubation
period of the disease is reported to be 2–14 days, however, there is evidence that it can last as long as 19–27 days [6].
The clinical manifestations of COVID-19 can range from asymptomatic mild disease to severe respiratory failure
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requiring hospital admission and mechanical ventilation [7]. The main clinical symptoms in COVID-19 patients
are fever, cough, fatigue and sore throat [8]. Significant differences in the clinical and demographic characteristics
of COVID-19 patients have been observed in different parts of the world.
Up till now a few studies have reported clinical characteristics and laboratory data of COVID-19 in Iran.
Shahriarirad et al. have performed a multicenter retrospective study on 113 hospitalized COVID-19 patients in
Fars province, located in the south of Iran [9]. In another study conducted by Nikpouraghdam et al., data regarding
the epidemiological features of 2968 COVID-19 patients in a hospital in Tehran (capital city and located in the
central part of Iran) have been reported [10]. Javanian et al. has also performed a retrospective cohort study on the
clinical symptoms and laboratory characteristics of 100 COVID-19 patients in Babol, in the North of Iran [11].
Although several studies have been reported, data on COVID-19 patients in different parts of Iran, no study
has characterized features of COVID-19 patients in Bushehr, a southern province of Iran. This study aimed to
investigate the clinical, laboratory and imaging findings of COVID-19 patients in Bushehr. The patients were
categorized into groups including inpatient, outpatient, elderly and nonelderly, and results were compared between
the four groups.
Materials & methods
Study design & population
From 29 April to 30 May 2020, a total of 900 patients suspected of COVID-19 infection were admitted to the
Shohadaye-Khalije-Fars Hospital, Nabi Akram Health Center, and Shahid Ganji. These three designated hospitals
are responsible for the management of COVID-19 patients in Bushehr province, Iran, assigned by the Iranian
Ministry of Health. Patients were divided into two groups, inpatients and outpatient. In our study, patients
presenting with mild or moderate symptoms, such as fever, cough, sore throat and dyspnea were categorized into
the outpatient group, while patients with severe symptoms like SpO2 <94%, PaO2/FiO2 <300 mmHg and
respiratory frequency >30 breaths per minute were inpatients. Furthermore, the patients were also categorized
into two groups, elderly (≥60 years old) and nonelderly (<60 years old) to compare clinical, laboratory and
computed tomography (CT) findings between different ages. Both oropharyngeal and nasopharyngeal specimens
were collected for each patient and combined into a viral transport medium to be tested as a single sample for
SARS-CoV-2. Samples were transferred to the virology department of Bushehr University of Medical Sciences under
refrigeration. The study was approved by the Ethics Committee of Bushehr University of Medical Sciences (ethic
code number: IR.BPUMS.REC.1399.004), and written informed consent was obtained from each participant
before enrollment.
Data collection
Patients were diagnosed with COVID-19 infection, according to the criterion of the WHO interim guidance [12].
For patients with confirmed COVID-19 infection, blood tests were performed on complete blood count analyzer
(Sysmex Corporation, Kobe, Japan) and SELECTRA automated analyzer (VitaLab, Dieren, The Netherlands), and
all data including laboratory results, epidemiological and demographic characteristics, clinical signs and symptoms,
and underlying conditions were recorded. Routine blood examinations were erythrocyte sedimentation rate (ESR),
complete blood count, serum biochemical tests (including blood urea nitrogen, Creatinine, Creatine Phosphokinase,
lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine transaminase, C-reactive protein).
CT examinations
The chest CTs were taken from all suspected individuals. For all individuals, chest CT evaluation was done on a
16-row multidetector scanner (Siemens Sensation 16, Erlangen, Germany) with the following parameters: 120 kV,
100–150 mA, 0.6 mm collimation and 1:1 pitch. Two radiologists with more than 5 years of experience evaluated
the CT findings in consensus and CT findings were classified as ground-glass opacities (GGOs), consolidation,
consolidation with GGOs, pleural effusion, ground glass and pleural effusion and normal.
Statistical analysis
Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) for Windows release 25.0
(SPSS Inc., IL, USA). Descriptive statistics (mean, standard deviation [SD], CI) were generated for demographic
and clinical characteristics. The normal distribution of parameters was analyzed using the Kolmogorov–Smirnov
test. Since the distribution of the variables did not follow a normal distribution, nonparametric tests were applied.
100 Future Virol. (2021) 16(2) future science group
COVID-19 in Bushehr, Iran Short Communication
Table 1. Association of the baseline data and clinical manifestations of the study subjects based on the type of admission
(inpatient or outpatient) and age group.
Characteristic Category Type of admission Age group







Sex Male 48 (50.5%) 30 (56.6%) 0.477 66 (55.9%) 12 (40%) 0.119
Female 47 (49.5%) 23 (43.4%) 52 (44.1%) 18 (60%)
Coexisting
conditions
Hypertension 5 (5.2%) 0 (0%) – 1 (0.8%) 4 (13.3%) 0.003
Type 2 diabetes 7 (7.3%) 1 (1.9%) 0.122 5 (4.2%) 3 (10%) 0.066
Chronic lung
diseases
4 (4.2%) 0 (0%) – 1 (0.8%) 3 (10%) 0.01
Cardiovascular
diseases
7 (7.3%) 0 (0%) – 4 (3.4%) 3 (10%) 0.041
Chronic blood
disorders
1 (1%) 0 (0%) – 1 (0.8%) 0 (0%) –
Hepatitis B 1 (1%) 0 (0%) – 0 (0%) 1 (3.3%) –
Bladder cancer 1 (1%) 0 (0%) – 0 (0%) 1 (3.3%) –
Down syndrome 1 (1%) 0 (0%) – 1 (0.8%) 0 (0%) –
None 68 (71.5%) 52 (98.1%) Reference† 105 (89%) 15 (50%) Reference†
Symptoms Fever 67 (70.5%) 27 (51%) 0.018 72 (61%) 22 (73.3%) 0.211
Cough 62 (65.3%) 21 (39.6%) 0.003 63 (53.4%) 20 (66.7%) 0.191
Dyspnea 54 (56.8%) 22 (41.5%) 0.075 60 (50.8%) 16 (53.3%) 0.808
Sore throat 12 (12.6%) 10 (18.9%) 0.309 19 (16.1%) 3 (10%) 0.402
Radiological
findings
GGO 33 (34.7%) 7 (13.2%) 0.0008 31 (26.3%) 9 (30%) 0.418
Consolidation 4 (4.2%) 1 (1.9%) 0.215 4 (3.4%) 1 (3.3%) 0.837
Consolidation plus
GGO
14 (17.7%) 2 (3.8%) 0.012 12 (10.2%) 4 (13.3%) 0.41
Pleural effusion 1 (1%) 0 (0%) – 0 (0%) 1 (3.3%) –
GGO and pleural
effusion
1 (1%) 0 (0%) – 0 (0%) 1 (3.3%) –
Normal 42 (44.2%) 43 (81.2%) Reference† 71 (60.2%) 14 (46.7%) Reference†
Outcome Alive 90 (94.8%) 53 (100%) – 116 (98.3%) 27 (90%) 0.025
Dead 5 (5.2%) 0 (0%) 2 (1.7%) 3 (10%)
†The base state for statistical comparison.
GGO: Ground glass opacity.
Mann–Whitney U test was used to compare the measurements between groups. Odds ratio with a 95% CI was used




From 29 April to 30 May 2020, a total of nine hundred cases suspected of COVID-19 infection were admitted to our
hospitals. After screening, 148 patients (16.4%) were confirmed to have COVID-19 infection by real-time reverse
transcription-PCR (rRT-PCR); 53 (35.8%) of those 148 patients were outpatients and 95 (64.2%) were inpatients.
The ages of patients with COVID-19 infection ranged from 1 to 90 years (mean age of 44.49 ± 17.4 years), and
over half of the patients (52.7%) were men. The mean age of the subjects in the inpatient and outpatient groups
were 48.89 ± 17.69 and 38.00 ± 15.78, respectively (p < 0.001). According to the sex distribution, inpatients
were composed of 48 (50.5%) males and 47 (49.5%) females. However, 30 (56.6%) males and 23 (43.4%) females
were included in the outpatient group (Table 1). In the inpatient group, 5 (5.2%) death cases were seen, while no
death case was detected in the outpatients.
Comorbidities & clinical manifestations
Inpatients showed underlying medical conditions more frequently than the outpatients. The most common
coexisting medical conditions in the inpatient group were Type 2 diabetes (n = 7; 7.3%) and cardiovascular diseases
future science group www.futuremedicine.com 101
Short Communication Keshavarz, Tavakoli, Zanganeh et al.
Table 2. Baseline data and paraclinical findings of the study participants.
Characteristic Type of admission Age
Inpatient (n = 95) Outpatient (n = 53) p-value† Nonelderly (n = 118) Elderly (n = 30) p-value†
Age (year) 48.89 ± 17.69 38.00 ± 15.78 0.001 38.03 ± 12.6 70.15 ± 8.14 0.0001
WBC (109/l) 6.60 ± 3.31 6.41 ± 2.12 0.39 6.42 ± 2.84 6.94 ± 3.3 0.882
Lymphocyte (109/l) 1.36 ± 0.76 2.04 ± 0.90 0.0001 1.69 ± 0.92 1.27 ± 0.58 0.002
ESR (mm/h) 44.99 ± 26.48 17.95 ± 17.97 0.0001 29.52 ± 23.98 56.65 ± 27.25 0.0001
CRP (mg/l) 49.02 ± 35.72 15.49 ± 24.55 0.0001 31.62 ± 34.22 57.09 ± 35.39 0.001
BUN (mg/dl) 17.36 ± 13.26 14.09 ± 4.28 0.84 15.12 ± 10.96 20.1 ± 10.69 0.001
Creatinine (mg/dl) 1.13 ± 0.67 0.98 ± 0.23 0.48 1.01 ± 0.45 1.3 ± 0.82 0.003
CPK (IU/l) 192.98 ± 244.41 138.35 ± 148.30 0.41 175.62 ± 229.36 166.84 ± 165.08 0.958
LDH (U/l) 559.57 ± 380.54 358.97 ± 119.83 0.0001 480.01 ± 351.58 520.11 ± 226.51 0.049
AST (U/l) 38.84 ± 38.77 26.16 ± 13.66 0.001 35.45 ± 36.25 30.5 ± 13.93 0.969
ALT (U/l) 36.77 ± 45.99 30.16 ± 22.38 0.39 36.67 ± 43.4 26.46 ± 16.83 0.146
†Nonparametric, Mann–Whitney U was used for between groups analysis.
ALT: Alanine Aminotransferase; AST: Aspartate aminotransferase; BUN: Blood urine nitrogen; CRP: C-reactive protein; CPK: Creatine kinase; ESR: Erythrocyte sedimentation rate; LDH:
Lactate dehydrogenase; WBC: White blood cell.
(n = 7; 7.3%), followed by hypertension (n = 5; 5.2%) and chronic lung diseases (n = 4; 4.2%). Among outpatients,
only 1 (1.9%) patient had Type 2 diabetes, whereas 52 patients (98.1%) did not present underlying diseases
(Table 1).
Fever was the most common clinical presentation among both inpatients and outpatients (70.5 and 51%,
respectively). The cough was the second most frequently observed symptom among inpatients, found in 65.3% of
patients, while it was observed in 39.6% of outpatients. Dyspnea was more common among inpatients (56.8%)
than in outpatients (41.5%) (Table 1).
Laboratory findings
Considering the blood leukocytes, the count of WBCs had no significant difference between the two groups
(6.60 ± 3.31 vs 6.41 ± 2.12; p = 0.39). However, lymphocyte counts were lower in the inpatient group in
comparison with the outpatient group (1.36 ± 0.76 vs 2.04 ± 0.90; p < 0.0001). Concerning the inflammatory
markers, ESR was significantly higher in the inpatients in comparison with the outpatients (44.99 ± 26.48
vs 17.95 ± 17.97; p < 0.0001). Additionally, CRP level was significantly higher among the inpatients than the
outpatients (49.02 ± 35.72 vs 15.49 ± 24.55; p < 0.0001; Table 2). Both blood urine nitrogen (BUN) and
creatinine levels were higher in the inpatients in comparison with the outpatients, but the differences were not
statistically significant (p = 0.84 and p = 0.48, respectively). Moreover, CPK levels did not have a significant
change between the two groups (p = 0.41). However, the LDH level was higher among the inpatients than the
outpatients (559.57 ± 380.54 vs 358.97 ± 119.83; p < 0.0001). Among the liver enzymes, the AST level was
significantly higher in the inpatient group compared with the outpatient group (38.84 ± 38.77 vs 26.16 ± 13.66;
p < 0.001). However, no statistically significant difference was detected between the two groups (36.77 ± 45.99
vs 30.16 ± 22.38; p = 0.39; Table 2).
Regarding the age group, results showed a significant increase in the levels of ESR among the elderly patients
(56.65 ± 27.25 mm/h) compared with the nonelderly patients (29.52 ± 23.98 mm/h) (p < 0.0001). Also, the
levels of CRP were significantly different between these groups, so that a higher level was observed among the
elderly patients (57.09 ± 35.39 mg/l) than the nonelderly ones (31.62 ± 34.22 mg/l). Similarly, higher levels of
BUN and LDH were seen in elderly patients compared with nonelderly patients (Table 2).
Comparison of radiographic findings
According to the chest CT examinations, GGOs were observed in 33 (34.7%) inpatients and 7 (13.2%) outpatients
and the difference was statistically significant (p = 0.0008). Additionally, consolidation in conjunction with ground
glass opacities was detected in 14 (17.7%) inpatients and 2 (3.8%) outpatients and the difference was statistically
significant (p = 0.012). Also, according to the comparison based on the age of patients, no significant findings were
seen in lung CT scans (Table 1 & Figure 1).
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Figure 1. Representative computed
tomography images of patients with
coronavirus disease-2019. (A) Female,
27 years old (outpatient) with fever
and dyspnea. Axial ccmputed
tomography (CT) image showed
normal lung markings. (B) Female, 35
years old (inpatient with alive
outcome) with fever and dyspnea.
Axial CT image showed small bilateral
areas of ground-glass opacities. (C)
Male, 74 years old (elderly) with fever,
cough and dyspnea. Axial CT image
shows larger ground-glass opacities in
the right lung. (D) Male, 31 years old
(nonelderly) with fever and
cough. Axial CT image shows
ground-glass opacities in the bilateral
lungs.
Discussion
In the face of the great threat posed by COVID-19 to human health, laboratory assessment and early prognosis of
the patient’s condition should be given more attention. Currently, the rapid spread of COVID-19 in Bushehr, a
province in southern Iran, has led to a dramatic increase in the number of hospitalized patients as well as increased
mortality in recent weeks. In this descriptive study, 148 patients confirmed with COVID-19 were evaluated.
Patients were divided into the outpatient and inpatient groups, and clinical symptoms, laboratory parameters and
chest CT features were evaluated.
Since SARS-CoV-2 is a novel pathogen, pre-existing immunity is not present in the human community, which
makes all humans susceptible to the infection. In high-risk groups such as elderly people and individuals with
co-existing comorbidity, the outcome of infection with SARS-CoV-2 will be more serious [13]. Our results showed
that among underlying medical comorbidities, Type 2 diabetes, cardiovascular diseases and hypertension were the
most common in all patients with COVID-19. Besides, the frequency of comorbidities was higher in the inpatients
compared with the outpatients. These results are consistent with the findings of another study conducted by
Nikpouraghdam et al. in Iran [10]. They found that diabetes, hypertension and cardiovascular diseases are among
the most common comorbidities in COVID-19 patients. In another investigation performed by Norooznezhad
et al., on 431 patients with a definite diagnosis for COVID-19 infection, underlying medical comorbidities such
as cardiovascular diseases and diabetes were the most frequently identified comorbidities [14]. Shahriarirad et al.
carried out a study on 113 hospitalized confirmed cases of COVID-19 admitted to hospitals in Shiraz [9]. Similar to
our findings, hypertension, diabetes and cardiovascular diseases were the most prevalent underlying comorbidities
among hospitalized patients with COVID-19.
Laboratory parameters are pivotal in helping us to identify COVID-19 cases and can use in the understanding
of the disease course, prognosis and the decision-making process. As a prominent result, a significant decrease
in lymphocyte counts among the inpatients compared with the outpatients were observed, and the decrease was
more remarkable in elderly patients. In parallel with our findings, several recent studies have been suggested that
lymphopenia is a strong indicator of infection with COVID-19 [15–18]. According to the results of a recent meta-
analysis, COVID-19 patients presenting lymphopenia have an approximately fivefold increased risk to develop a
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severe form of the disease [19]. Several potential mechanisms leading to the lymphocyte depletion have been proposed
such as direct infection and death of lymphocytes by the virus, destroying lymphatic organs and lymphocytes
inhibition by metabolic molecules produced by metabolic disorders [20]. Tavakolpour et al. hypothesized several
possible underlying causes for the lymphopenia in severe COVID-19 patients including the inflammatory cytokine
storm, exhaustion of T cells, direct infection of T cells by SARS-CoV-2 and interference with T cell expansion [21].
Levels of ESR, CRP, LDH and AST among inpatients were higher than the outpatients in our study, and
the results are in accordance with the previous studies. It has been documented that elevated LDH levels are
associated with worse outcomes in COVID-19 patients [22]. LDH is a metabolic enzyme that is found in nearly all
major organ cells and its elevation is usually indicative of tissue damage. The SARS-CoV-2 binds to angiotensin
converting enzyme 2 (ACE2) receptor on human lung, and accordingly, the lung is the first affected organ. However,
abnormalities in cytokine profiles and dysfunction in multiple organs can be found when the disease progresses [23],
suggesting the virus can affect other organs. In addition to the lungs, ACE2 is expressed on other tissues such as
heart, kidney and GI tract [24] and this can explain why multiple organs are afflicted during COVID-19 infection.
One of the striking findings of the present study is that there was no significant difference in the levels of
creatinine and BUN between the inpatients and outpatients, while the difference was observed between elderly and
nonelderly patients. Consistent with our results, a study conducted by Guo et al. showed a higher median level of
creatine and BUN than young patients [25]. BUN is a well-known biomarker of kidney function, and these findings
indicate that COVID-19 infection is associated with more severe renal failure and abnormalities in elderly patients
than young ones.
Our findings showed that the prevalence of GGO and pulmonary consolidations were significantly higher among
inpatients compared with outpatients. This is in line with the results of the recent meta-analysis conducted by
Sun et al. They reported that GGO, consolidation, and GGO plus consolidation were the most common findings
reported in 94.5% of the studies [26]. Also based on another comprehensive study conducted by Güneyli et al., the
most common CT findings of COVID-19 patients were GGO, consolidation and GGO plus consolidation [27].
There are several limitations to our study that should be considered. First, due to the study design, some
important laboratory parameters and biomarkers were not measured in our patients, such as D-dimer, B-type
natriuretic peptide (BNP), N-terminal pro b-type natriuretic peptide (NT-proBNP) and pocalcitonin. Second,
because of the small sample size in the study, our analyses are low in power. Third, the number of patients under
the age of 18 was limited, therefore, we could not perform any analysis on pediatric patients with COVID-19.
Conclusion
Based on our data, underlying diseases were more frequent in inpatients than in outpatients. The most common
underlying diseases in the inpatient group were Type 2 diabetes, cardiovascular diseases, hypertension and chronic
lung diseases. Fever and cough were the most common symptom observed among inpatients. Moreover, the levels
of BUN and creatinine in elderly patients were higher than in young patients, suggesting that COVID-19 infection
is associated with more renal failure in elderly patients. Furthermore, most of the hospitalized patients had GGO
or mixed GGO and consolidation lesions in the chest CT findings.
Summary points
• From 29 April to 30 May 2020, a total of 148 patients confirmed with coronavirus disease-2019 infection were
admitted to three hospitals in Bushehr, a province in the south of Iran.
• Among the patients, 35.8% were outpatients and 64.2% were inpatients.
• The mean age of inpatients and outpatients was 48.89 ± 17.69 and 38.00 ± 15.78, respectively.
• The frequency of underlying disease among inpatients was higher than outpatients.
• The most common underlying disease in all patients was Type 2 diabetes.
• Ground glass opacities were observed in lung CT images of 34.7% of inpatients and 13.2% of outpatients.
• Levels of erythrocyte sedimentation rate, CRP, lactate dehydrogenase and aspartate aminotransferas among
inpatients were higher than outpatients.
• A significant increase was seen in the levels of erythrocyte sedimentation rate, blood urine nitrogen, CRP and
lactate dehydrogenase among elderly patients compared with nonelderly patients.
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